Only 1 in 5 US nursing home residents given monoclonal antibodies, antivirals for COVID

A new study published in JAMA finds that fewer than one in five US nursing home residents received evidenced-based treatment with monoclonal antibodies or oral antiviral drugs for COVID-19, despite being at high risk for poor outcomes. The rate had improved to one in four by late 2022. Researchers from the University of Rochester and Harvard used the Centers for Disease Control and Prevention’s…

Read the full article here

Related Articles